Local Infiltration Analgesia With Liposomal Bupivacaine Improves Pain Scores and Reduces Opioid Use After Total Knee Arthroplasty: Results of a Randomized Controlled Trial.
暂无分享,去创建一个
[1] D. Schroeder,et al. A Three-arm Randomized Clinical Trial Comparing Continuous Femoral Plus Single-injection Sciatic Peripheral Nerve Blocks versus Periarticular Injection with Ropivacaine or Liposomal Bupivacaine for Patients Undergoing Total Knee Arthroplasty , 2017, Anesthesiology.
[2] C. Asche,et al. Local infiltration for postsurgical analgesia following total hip arthroplasty: a comparison of liposomal bupivacaine to traditional bupivacaine , 2017, Current medical research and opinion.
[3] J. Parvizi,et al. Periarticular Injection of Liposomal Bupivacaine Offers No Benefit Over Standard Bupivacaine in Total Knee Arthroplasty: A Prospective, Randomized, Controlled Trial. , 2017, The Journal of arthroplasty.
[4] K. Slavin,et al. Responsible, Safe, and Effective Prescription of Opioids for Chronic Non-Cancer Pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines. , 2017, Pain physician.
[5] A. Lombardi,et al. No Difference in Early Analgesia Between Liposomal Bupivacaine Injection and Intrathecal Morphine After TKA , 2017, Clinical orthopaedics and related research.
[6] Michael A Mont,et al. A Randomized, Multicenter, Double-Blind Study of Local Infiltration Analgesia with Liposomal Bupivacaine for Postsurgical Pain Following Total Knee Arthroplasty: Rationale and Design of the Pillar Trial. , 2016, Surgical technology international.
[7] R. Jain,et al. The AAHKS Clinical Research Award: Liposomal Bupivacaine and Periarticular Injection Are Not Superior to Single-Shot Intra-articular Injection for Pain Control in Total Knee Arthroplasty. , 2016, The Journal of arthroplasty.
[8] J. Rinehart,et al. Is There a Benefit for Liposomal Bupivacaine Compared to a Traditional Periarticular Injection in Total Knee Arthroplasty Patients With a History of Chronic Opioid Use? , 2016, The Journal of arthroplasty.
[9] C. Asche,et al. Cost-benefit evaluation of liposomal bupivacaine in the management of patients undergoing total knee arthroplasty. , 2016, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
[10] Song-lin Tong,et al. Local Infiltration Analgesia Versus Regional Blockade for Postoperative Analgesia in Total Knee Arthroplasty: A Meta-analysis of Randomized Controlled Trials. , 2016, Pain physician.
[11] R. Meneghini,et al. Liposomal Bupivacaine Injection Technique in Total Knee Arthroplasty , 2016, Journal of Knee Surgery.
[12] J. Carter,et al. Comparison of Intraoperative Periarticular Injections versus Liposomal Bupivacaine as Part of a Multimodal Approach to Pain Management in Total Knee Arthroplasty , 2016, Hospital pharmacy.
[13] A. Malkani,et al. Periarticular Injection After Total Knee Arthroplasty Using Liposomal Bupivacaine vs a Modified Ranawat Suspension: A Prospective, Randomized Study. , 2016, The Journal of arthroplasty.
[14] Roger Chou,et al. Management of Postoperative Pain: A Clinical Practice Guideline From the American Pain Society, the American Society of Regional Anesthesia and Pain Medicine, and the American Society of Anesthesiologists' Committee on Regional Anesthesia, Executive Committee, and Administrative Council. , 2016, The journal of pain : official journal of the American Pain Society.
[15] M. Snyder,et al. Improving total knee arthroplasty perioperative pain management using a periarticular injection with bupivacaine liposomal suspension , 2016, Arthroplasty today.
[16] Joseph W. Frank,et al. Opioid Prescribing at Hospital Discharge Contributes to Chronic Opioid Use , 2016, Journal of General Internal Medicine.
[17] M. Kelly. Current Postoperative Pain Management Protocols Contribute to the Opioid Epidemic in the United States. , 2015, American journal of orthopedics.
[18] Heather N. Watson,et al. Liposomal Bupivacaine: A Comparative Study of More Than 1000 Total Joint Arthroplasty Cases. , 2015, The Orthopedic clinics of North America.
[19] W. Schroer,et al. Does Extended-Release Liposomal Bupivacaine Better Control Pain Than Bupivacaine After Total Knee Arthroplasty (TKA)? A Prospective, Randomized Clinical Trial. , 2015, The Journal of arthroplasty.
[20] P. Zan,et al. The Comparison of Local Infiltration Analgesia with Peripheral Nerve Block following Total Knee Arthroplasty (TKA): A Systematic Review with Meta-Analysis. , 2015, The Journal of arthroplasty.
[21] B. Morris,et al. The opioid epidemic: impact on orthopaedic surgery. , 2015, The Journal of the American Academy of Orthopaedic Surgeons.
[22] J. Jauregui,et al. New and Common Perioperative Pain Management Techniques in Total Knee Arthroplasty , 2015, The Journal of Knee Surgery.
[23] A. Lombardi,et al. Techniques for periarticular infiltration with liposomal bupivacaine for the management of pain after hip and knee arthroplasty: a consensus recommendation. , 2015, Journal of surgical orthopaedic advances.
[24] R. Butler,et al. Use of Liposomal Bupivacaine Instead of an Epidural Can Improve Outcomes Following Total Knee Arthroplasty. , 2015, Journal of surgical orthopaedic advances.
[25] S. Mears,et al. Technique for Periarticular Local Infiltrative Anesthesia Delivery Using Liposomal Bupivacaine in Total Knee Arthroplasty. , 2015, Journal of surgical orthopaedic advances.
[26] J. Popovich,et al. Comparison Between Liposomal Bupivacaine and Femoral Nerve Block in Patients Undergoing Primary Total Knee Arthroplasty. , 2015, Journal of surgical orthopaedic advances.
[27] T. Halaszynski,et al. Perioperative pain management in hip and knee replacement surgery. , 2014, American journal of orthopedics.
[28] E. Viscusi,et al. Perioperative pain management for total knee arthroplasty. , 2014, Journal of surgical orthopaedic advances.
[29] C. Howie,et al. What determines patient satisfaction with surgery? A prospective cohort study of 4709 patients following total joint replacement , 2013, BMJ Open.
[30] M. Shah,et al. Cost and Quality Implications of Opioid‐Based Postsurgical Pain Control Using Administrative Claims Data from a Large Health System: Opioid‐Related Adverse Events and Their Impact on Clinical and Economic Outcomes , 2013, Pharmacotherapy.